E
Bright Minds Biosciences Inc. DRUG
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 34.86% 13.03% -14.46% -35.42% -29.56%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 143.64% 0.10% -61.83% -63.97% -61.01%
Operating Income -143.64% -0.10% 61.83% 63.97% 61.01%
Income Before Tax -141.33% 38.24% 84.50% 62.55% 60.02%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -141.33% 38.24% 84.50% 62.55% 60.02%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -141.33% 38.24% 84.50% 62.55% 60.02%
EBIT -143.64% -0.10% 61.83% 63.97% 61.01%
EBITDA -- -- -- -- --
EPS Basic -38.43% 63.11% 86.67% 65.79% 65.67%
Normalized Basic EPS -38.41% 63.14% 86.69% 65.80% 65.67%
EPS Diluted -38.07% 62.97% 86.43% 65.52% 65.55%
Normalized Diluted EPS -38.48% 63.09% 86.65% 65.80% 65.67%
Average Basic Shares Outstanding 49.69% 39.69% 28.95% 15.59% 18.86%
Average Diluted Shares Outstanding 52.57% 42.70% 32.09% 15.59% 18.86%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --